BioSpace News Archive

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) this week shared new data revealing the burden of chronic hypoparathyroidism on patients and caregivers, as well as potential long-term risks of renal and cardiovascular complications that patients treated with conventional therapy may experience

EarlySense, the market leader in contact-free continuous monitoring solutions across the care continuum, announced today the results of a randomized controlled clinical study conducted at the University of Chicago, which found significant benefit to low-risk patients who are not woken during the night for vital sign assessments.

New Ventures BC and BioTalent Canada today announced a new partnership to assist BC biotech companies to access funding to hire post-secondary students for business and tech roles to help drive their objectives forward.

Tufts Health Freedom Plan has launched a new mobile application that will give members the ability to check claims and benefits, shop for coverage, and search for providers.

Perspectum has been named by Beauhurst as the fastest growing Life Science Company in the UK

A critical focus for the FDA is preventing and mitigating potential medical product shortages.

Product claims on insect repellents are some of the best-read items on spray cans. And, over-the-counter pharmaceutical companies continually research their products to provide data that supports their product claims.

Founded in 2007, UrgentMED Network entered the healthcare industry with the goal of revolutionizing patient care. With a patient-centric approach to diagnosis and care, they worked tirelessly to provide exemplary health care that was efficient, effective and affordable.

Managing access to gene therapy, mitigating risk of inappropriate opioid utilization, the current state of value-based contracting, and drug pricing reform efforts are just some topics of the nearly 40 educational sessions taking place at the Academy of Managed Care Pharmacy Managed Care & Specialty Pharmacy Annual Meeting this week in San Diego.

Pulse Biosciences, Inc. announced that key findings from its clinical programs using Nano-Pulse Stimulation™ technology will be presented at the American Society for Laser Medicine and Surgery’s Annual Conference being held March 27-31, 2019, in Denver, CO.